BF Biosciences Limited (PSX:BFBIO)
Pakistan
· Delayed Price · Currency is PKR 131.13
-7.73 (-5.57%)
At close: Mar 9, 2026
BF Biosciences Cash Flow Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2019 |
| Net Income | 598.64 | 447.15 | 385.41 | 149.05 | 306.98 | 607.99 | Upgrade
|
| Depreciation & Amortization | 280.12 | 191.92 | 35.57 | 33.78 | 28 | 23 | Upgrade
|
| Other Amortization | 1.98 | 1.69 | 0.55 | 0.55 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.36 | -2.79 | -2.13 | -1.06 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -57.62 | -27.3 | -0.21 | -8.93 | - | - | Upgrade
|
| Other Operating Activities | 148.98 | 44.33 | 305.49 | 32.12 | -156.98 | -60.99 | Upgrade
|
| Change in Accounts Receivable | -357.29 | 20.37 | -110.82 | -41.1 | - | - | Upgrade
|
| Change in Inventory | -1,178 | -846.4 | -41.57 | -445.69 | - | - | Upgrade
|
| Change in Accounts Payable | 1,338 | 472.43 | 196.75 | -5.94 | - | - | Upgrade
|
| Change in Unearned Revenue | 90.67 | -5.27 | 19.75 | -17.78 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -174.53 | 3.66 | -124.09 | 108.94 | - | - | Upgrade
|
| Operating Cash Flow | 714.17 | 299.79 | 664.7 | -196.07 | 178 | 570 | Upgrade
|
| Operating Cash Flow Growth | 27.64% | -54.90% | - | - | -68.77% | - | Upgrade
|
| Capital Expenditures | -380.93 | -329.49 | -143.13 | -1,968 | -1,130 | -941 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.52 | 3.86 | 4.4 | 1.06 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -1.66 | - | - | Upgrade
|
| Investment in Securities | 525.81 | -1,100 | 108.58 | 1,161 | - | - | Upgrade
|
| Other Investing Activities | 12.05 | 91 | 16.34 | 83.4 | -333 | -399 | Upgrade
|
| Investing Cash Flow | 163.45 | -1,335 | -13.81 | -724.44 | -1,463 | -1,340 | Upgrade
|
| Long-Term Debt Issued | - | 93.55 | - | 811.02 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -436.19 | -321.36 | -50.5 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -441.52 | -342.64 | -321.36 | 760.52 | - | - | Upgrade
|
| Issuance of Common Stock | - | 1,855 | - | - | - | - | Upgrade
|
| Other Financing Activities | -86.96 | -112.25 | -161.52 | -120.28 | 925 | 1,162 | Upgrade
|
| Financing Cash Flow | -528.47 | 1,400 | -482.88 | 640.24 | 925 | 1,162 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 | 1 | Upgrade
|
| Net Cash Flow | 349.15 | 365.04 | 168.02 | -280.27 | -359 | 393 | Upgrade
|
| Free Cash Flow | 333.25 | -29.71 | 521.57 | -2,164 | -952 | -371 | Upgrade
|
| Free Cash Flow Margin | 4.05% | -0.51% | 14.26% | -119.61% | -62.60% | -21.14% | Upgrade
|
| Free Cash Flow Per Share | 3.77 | -0.37 | 8.23 | -34.17 | -15.03 | -5.86 | Upgrade
|
| Cash Interest Paid | 86.96 | 112.25 | 161.52 | 120.28 | - | - | Upgrade
|
| Cash Income Tax Paid | 257.34 | 279.05 | 51.39 | 73.4 | - | - | Upgrade
|
| Levered Free Cash Flow | 226.73 | -255.5 | 313.25 | -2,306 | -834 | -670.45 | Upgrade
|
| Unlevered Free Cash Flow | 274.92 | -183.39 | 401.52 | -2,306 | -792.99 | -654.66 | Upgrade
|
| Change in Working Capital | -280.84 | -355.21 | -59.98 | -401.58 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.